Study of the risk factors for severe childhood pertussis based on hospital surveillance data (Q31122163)

29 June 2017

title

Study of the risk factors for severe childhood pertussis based on hospital surveillance data (English)

1 reference

29 June 2017

Valérie Briand

1

1 reference

29 June 2017

Isabelle Bonmarin

series ordinal

2

1 reference

29 June 2017

Daniel Lévy-Bruhl

series ordinal

3

1 reference

29 June 2017

language of work or name

English

0 references

publication date

2 August 2007

1 reference

29 June 2017

1 reference

29 June 2017

volume

25

1 reference

29 June 2017

issue

41

1 reference

29 June 2017

page(s)

7224-7232

1 reference

Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Resurgence of pertussis in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Outcomes of Bordetella pertussis infection in different age groups of an immunized population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Vaccine coverage of pre-school age children in France in 2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Bordetella pertussis surveillance in England and Wales: 1995-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Intensity of exposure and severity of whooping cough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Epidemiological features of pertussis in the United States, 1980-1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Epidemiological Features of Pertussis in Hospitalized Patients in Canada, 1991‐1997: Report of the Immunization Monitoring Program–Active (IMPACT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an eleven-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Delayed immunisation and risk of pertussis in infants: unmatched case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

Effects of Pertussis Vaccination on Disease: Vaccine Efficacy in Reducing Clinical Severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2007.07.020

10.1016/J.VACCINE.2007.07.020

7 January 2021

Identifiers

DOI

1 reference

29 June 2017

1 reference